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Take-home Message / Tweet: Despite stunting, survivors of acute malnutrition don’t have worse 
lung function than controls, suggesting possible adaptive thrifty growth   
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ABSTRACT 
The question addressed: Early nutritional insults may increase risk of adult lung disease.  We aimed 
to quantify the impact of severe acute malnutrition (SAM) on spirometric outcomes 7 years’ post-
treatment and explore predictors of impaired lung function. 
Methods: Spirometry and pulse oximetry were assessed in 237 Malawian children (median age: 9·3; 
range: 7·6-15·3 years) treated for SAM and compared with sibling and age/sex-matched community 
controls. Spirometry results were expressed as z-scores based on “Global Lung Function (GLI) Black” 
reference data. 
Results: Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC) was low in 
all groups (mean FEV1 z-score: -0.47 for cases, -0.48 for siblings and -0.34 for community controls; 
mean FVC z-score being -0.32, -0.38, and -0.15 respectively). There were no differences in spirometric 
or oximetry outcomes between SAM survivors and controls. Leg length was shorter in SAM survivors 
but inter-group sitting heights were similar. Being HIV+ve or female were associated with poorer FEV1, 
by 0·55 and 0·31 z-scores respectively.     
The answer: SAM in early childhood was not associated with subsequent reduced lung function 
compared to local controls. Preservation of sitting height and compromised leg length could suggest 
“thrifty” or “lung-sparing” growth. Girls and those with HIV were identified as potentially “high risk” 
groups.  
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INTRODUCTION 
The Developmental Origins of Health and Disease (DOHaD) theory proposes that environmental 
exposures (such as nutritional insults), during critical time “windows” in early life, have long term 
implications for adult health, particularly non-communicable diseases (NCDs)[1]. Respiratory illness 
is no exception; there is evidence that early nutritional insults, both prenatally and during early infancy, 
result in higher risk of chronic obstructive pulmonary disease (COPD) and asthma[2, 3]. Exact 
mechanisms behind DOHaD are not currently known, but it is hypothesised that disruption of lung 
development, particularly alveologenesis, could lead to chronic lung disease in adulthood, particularly 
when compounded by adverse environmental factors[4, 5]. Since the majority of alveologenesis is 
thought to occur before the age of 2 years[6], nutritional insults during this period could result in long-
term impairments. In particular, severe acute malnutrition (SAM), which is most prevalent in the first 
two years of life, might have an important biological link to long-term respiratory disease.  
SAM affects more than 19 million children under 5 years worldwide [7, 8] and is defined as low weight-
for-height (below -3 z-scores using WHO growth standards) or a low mid upper arm circumference 
(MUAC) (<115mm) or presence of oedematous malnutrition[9] (see Annex 1 for a Glossary of nutrition 
terms and definitions). Although some studies have considered the effects of chronic undernutrition 
(also known as stunting)[10, 11] and micronutrients [12, 13] on lung function, there is very little 
evidence regarding the long-term effects of SAM on lung function. 
Understanding whether SAM during infancy and childhood has lasting effects on lung function could 
facilitate development of interventions aiming to curb the growing burden of NCDs in developing 
countries and improve survival and long-term outcomes post-SAM. The aim of this study was to 
quantify the long-term (7 year) effects of SAM on spirometry outcomes, as well as explore predictors 
of poor lung function, including severity of stunting and wasting, presence of oedema at admission, 
exposure to household cooking smoke, sex, and HIV, in a cohort of Malawian SAM survivors[14, 15].  
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MATERIALS AND METHODS 
Study Design  
This was a longitudinal cohort study which prospectively followed-up ex-SAM ‘case children’. We 
estimated that we would locate and recruit 300 case children plus one sibling and one community 
control per case. This was sufficient for detecting differences in lung function between groups 
equivalent to 0.5 z-scores (>90% power, 5% significance), generally thought to be the cut-off for 
clinical significance[16]. 
Ethical approval for this study was granted by Malawi College of Medicine Research and Ethics 
Committee (COMREC) (reference P·02/13/1342); and University College London Research Ethics 
Committee (reference 4683/001). Besides lung function, other outcomes were also studied: fuller details 
of the cohort, as well as additional methods and results have been described elsewhere[17, 18].  
Study setting and subjects 
The cohort originally included all patients admitted to the nutrition ward for treatment of SAM in Queen 
Elizabeth Central Hospital, Blantyre, Malawi, from 12th July 2006 to 9th March 2007 (1024 children). 
The median age of the children at admission was 21.5 months (interquartile range 15-32 months). 
Results of survival and anthropometry at the baseline study and the 1 year follow-up have been 
described previously[14, 15]. 47% (477/1024) of the original cohort were known to be alive 1-year 
post-discharge; these children formed the “case group” for this study. The sibling control was that 
closest in age to the case child, between the ages of 6 and 15·9 years. Those younger than six years 
were not eligible for spirometry testing, due to the difficulty in obtaining high quality spirometry in 
very young children under field conditions. The community control was defined as a child living in the 
same community, of the same sex, and within 12 months of age of the case child, randomly selected by 
spinning a bottle at the case child’s home to select a random direction, then enquiring door-to-door to 
find the first eligible child. Children who had ever been treated for acute malnutrition were excluded 
from the control groups. Informed written consent was obtained from the child’s parent or guardian; 
assent was required from the children themselves. Possible sources of missing data included cases who 
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could not be located, those who agreed to participate but then did not attend the hospital appointment 
(more often community controls) and those who failed to achieve acceptable quality spirometry data.  
Variables   
Primary lung function outcomes were forced expiratory volume in 1 second (FEV1), forced vital 
capacity (FVC) and the FEV1/FVC ratio expressed as z-scores, based on the Global Lung function 
Initiative (GLI) Black reference equations (based on the African-American population), which adjust 
for standing height, age, sex and ethnicity[16]. Spirometry testing took place in our study room at the 
hospital using the Easy on-PC spirometer (NDD medical, Zurich, Switzerland), operated by NL or EC, 
and one of three trained data collectors. Quality control of acceptable spirometry traces was undertaken 
weekly by NL.  JK, who was blinded to study groups, checked 40% of results. The criteria for 
acceptability and repeatability of the spirometry curves was based on  ATS/ERS recommendations 
adapted slightly for children[19, 20].  
Duplicate measures by independent data collectors were made for height and sitting height to the nearest 
0.1cm (Leicester height stadiometer, HM-250P, Marsden Weighing Group, UK), and weight to the 
nearest 0.1kg (MS4202L, Marsden group, Rotherham, UK), following the WHO method[21]. Weight-
for-age (WAZ), height-for-age (HAZ) and body mass index (BMI)-for-age (BAZ) z-scores were 
calculated using WHO 2007 growth standards[22]. HIV status was established from results in health 
passports; if unknown, a HIV test was offered by a trained counsellor, following Malawi national 
protocol (using Determine HIV-1/2 [Abbott Laboratories, USA] and Uni-Gold HIV [Trinity Biotech 
PLC, Ireland] tests). Puberty was recorded as a binary variable, as reported by the participant or 
guardian (onset of menarche in girls, voice change in boys). Since birthweight was rarely recorded, 
mothers were asked whether their child was “small” or “normal/large” at birth, during the baseline data 
collection; this follows a method widely used in Demographic and Health Surveys (DHS) 
(http://dhsprogram.com/). Pulse oximetry was used to measure oxygen saturation (SpO2) using the 
NONIN PalmSAT 2500 device (Nonin Medical Inc., USA) during the iStep exercise test (incremental 
step test) developed by UCL Institute of Child Health[23]. Body composition, including lean mass, was 
measured using bioelectrical impedance analysis (BIA) (Quadscan 4000; Bodystat Ltd, UK). A 
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questionnaire detailing contra-indications for spirometry and potential confounding factors, including 
cold symptoms, asthma, cooking fuel use, socioeconomic circumstances (SEC) and history of 
respiratory illness was also administered. These questions were based on the “American Thoracic 
Society’s ATS-DLD-78C respiratory questionnaire”, UCL’s “SLIC” study questionnaire and Malawi 
DHS[24-26]. History of respiratory illness was assessed by parental reporting. Exposure to household 
cooking smoke was defined as those reporting use of solid fuels for cooking inside the home.  
Analysis 
Primary analysis was based on all children with technically acceptable (grade A-C) spirometry results. 
Those with grade D results[19] (i.e. not repeatable) and those with reported current upper respiratory 
(cold) symptoms were also included as they were evenly spread across the sample and made no 
significant difference to final conclusions[27]. Basic demographic data for each study group as well as 
those cases lost-to-follow-up are presented (Table 1). Data for the three main spirometric outcomes and 
exercise test outcomes were examined by allocation group (Figure 2) and statistical differences assessed 
using simple and multivariable linear regression models (Table 2; Annex 2). One model was used for 
each outcome where the predictor was coded zero for cases, one for siblings and two for community 
controls. HIV status, age, sex, SEC derived from asset scores using DHS questions[26], and puberty 
were included as a priori potential confounders. For spirometric outcomes, sitting height as a percentage 
of standing height and leg length were also explored as potential confounders in further analysis. The 
difference in odds of completing the exercise test between allocation groups was calculated using 
multivariable logistic regression. 
For our secondary analysis, HIV status, SEC, sex, history of pneumonia, history of TB, cooking smoke 
exposure and body composition (lean/fat mass) were examined for their association with spirometry 
outcomes across the entire sample using linear regression. A sex-stratified analysis on cooking smoke 
exposure was also conducted to try to explain significant differences in spirometry found between the 
sexes. 
We also used linear regression to explore predictive factors of poor spirometry outcomes in the case 
group only. Namely, differences associated with severity of wasting and stunting at admission, presence 
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of oedema at admission, HIV status, sex, estimated birth size and age at admission (months) were 
calculated after adjusting for HIV, SEC and puberty (Table 3). A P-value of <0.05 was used as an 
indication of statistical significance throughout.   
 
RESULTS 
398/477 (83%) families were found; 32 declined to participate, 46 case children had died, and 320 case 
children were investigated. The study included 721 children in total (320 cases, 217 sibling controls 
and 184 community controls); those who attempted spirometry and the final number of technically 
acceptable results are described in Figure 1. The proportion of acceptable results was similar across the 
study groups (85% for cases, 87% for siblings and 92% for community controls). Although the study 
aimed to recruit one of each type of control per case, not all cases had an eligible sibling, and some 
community controls dropped out of the study prior to the hospital appointment. Exploration of important 
demographic and health characteristics for the 3 study groups and those cases lost to follow-up indicated 
that HIV was a key potential confounder in the case group (Table 1). All three groups had mean height, 
weight, and BMI z-scores below global reference norms (Table 1), however cases were significantly 
more stunted than siblings (adjusted mean (95% CI) height difference: -0·2 (-0·4 to -0·0) z-scores) and 
community controls (-0·4 (-0·6 to -0·2) z-scores) (see Annex 1: Glossary for definition of stunting). 
Further details of growth and survival outcomes are published elsewhere[28]. There was no statistically 
significant difference in chest circumference, chest depth, or sitting height between cases and controls 
but cases had a significantly shorter leg length than either sibling (adjusted difference -1·43cm, 95%CI 
-2·3 to -0·5) or community controls (adjusted difference: -1·97cm, 95%CI -3·0 to -1·0).   
Figure 1: Recruitment flow diagram for spirometry results 
Footnote: recruitment of sibling and community control only commenced at time of 7 year follow-up hence their 
recruitment history starts after that of cases, who were enrolled at admission.    
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Table 1: Demographic characteristics for the three study groups and those lost to follow-up.  
Basic Demographics Cases  
(n=237)  
Sibling controls 
(n=164) 
Community 
controls 
(n=131) 
Cases  
Lost to Follow Up 
(n=190) 
Age (years)a  9·3 (7·6-15·3) 11·5 (4·6-15·6) 9·1 (5·2-15·1) 8 (7 - 19) 
Males  128 (54%) 76 (46%) 68 (52%) 108 (57%) 
Birth Order b 2 (IQR 1-4) 2 (IQR 2-3) 2 (IQR1-3) 2 (IQR 1-3) 
Started puberty 7 (3%) 12 (7%) 6 (5%) N/A 
SEC (asset quintile)     
    1 (poorest) 50 (21%) 36 (22%) 22 (17%) N/A 
    5 (richest) 44 (19%) 28 (17%) 28 (21%) N/A 
HIV     
   Seropositive 65 (28%) 5 (3%) 3 (2%) 44 (23%) 
   Seronegative 155 (65%) 100 (61%) 75 (57%) 121 (64%) 
   Status unknown 17 (7%) 59 (36%) 53 (40%) 25 (13%) 
Height-for-age z-score  -1·8 (1·2) -1·5 (1·2) -1·3 (1·1) N/A  
Weight-for-age z-score -1·6 (1·0) -1·4 (1·0) -1·2 (1·0) N/A 
BMI-for-age z-score -0·8 (0·9) -0·8 (0·9) -0·7 (0·9) N/A  
Sitting height (%)  52·2 (1·5) 51·8 (1·7) 51·8 (1·5) N/A 
Sitting height (cm) 65.4 (4.3) 68.2 (7.1) 66.0 (4.7) N/A 
Leg Length (cm) 59·9 (5·5) 63·0 (9·6) 61·6 (6·0) N/A 
Lean Mass Index  9·02 (1·1) 9·20 (1·0) 9·12 (1·0) N/A 
Reported indoor biofuel 
use (wood/charcoal) 
37 (16%) ~16% 18 (14%) N/A 
Reported indoor tobacco 
use 
31 (13%) ~13% 19 (15%) N/A 
History of TB 11 (5%) 1 (0·6%) 1 (0·8%) 4/173 (2%) 
History of pneumonia 
admissions 
7 (3%) 13 (8%) 7 (5%) N/A 
Ever admitted to hospital 
(except SAM) 
47 (20%) 43 (26%) 38 (29%) N/A 
Results are presented as n (%) or mean (SD) unless otherwise indicated. a median (range), b median (IQR). 
Height-for-age z-score is based on WHO 2007 growth standards. Lean mass index is calculated from impedance 
results of bioelectrical impedance analysis (BIA) and height: a higher value implies more lean mass. Sitting 
height % = sitting height/standing height*100. History of TB, pneumonia and hospital admission were self-
reported. N/A = not applicable. Cases lost to follow-up are those who were admitted with SAM in the original 
cohort but could not be subsequently located. “~” for sibling controls indicates that this was not measured but 
assumed to be the same as for cases with whom they shared a household.  
 
Lung function differences across study groups 
Although most subjects had spirometry results within the normal range (i.e. within 0 ± 2 z-scores, see 
Figure 2), mean FEV1 was significantly lower than predicted in all the groups (by up to 0·47 z-
scores)[16]. Similar, albeit slightly smaller, deficits were observed for FVC. There were however no 
significant differences in FEV1, FVC or FEV1/FVC z-scores between cases and either type of control 
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(Table 2; Figure 2). This remained true when adjusting for sitting height or leg length in the regression 
model. Additionally, there were no significant differences in SpO2 either at rest or during the iStep 
exercise test between the study groups (Annex 2), although cases were less likely to complete the 
exercise test than controls (log odds of completing the test adjusted for age, sex, HIV status and SEC: -
0·27 (-0·8; 0·2) compared to siblings; -0·47 (-1·0; 0·0) compared to community controls). 
Figure 2: Lung function results for cases, siblings and community controls. 
Legend: Solid line with error bars represent mean ±1SD. Dashed lines indicate the limits of normality as per 
GLI-Black spirometry reference data (i.e. mean (0) ±1.96 z-scores). There were no statistically significant 
differences in any of the spirometry outcomes between the 3 groups. Most results fall within the normal range, 
however mean FEV1 and FVC were lower than predicted by the GLI reference for all 3 groups.   
 
Predictors of lung function in the whole sample 
Among the whole sample, FEV1 and FVC z-scores were significantly lower for HIV positive children 
than HIV negative children (0·5 and 0·4 z-scores lower respectively, unadjusted p <0.01 for both) with 
no significant difference in FEV1/FVC z-score (p=0·2). There was no difference in spirometry outcomes 
for those with a previous pneumonia admission, whereas in those with a history of TB (n=13; note small 
sample size), FEV1 and FVC were lower by mean (95%CI) 0·91 (-1·5;-0·3) and 1·07 (-1·7;-0·4) z-
scores respectively (unadjusted p<0·001 for both). 
Although there was no difference in FEV1/FVC; FEV1 and FVC z-scores were both significantly lower 
in girls than boys for the sample as a whole (unadjusted difference (95% CI): -0.28 (-0.5;-0.1) z-scores, 
p=0·004, and -0.25 (-0.4;-0.1) z-scores, p= 0·012, respectively). These statistically significant deficits 
remained after adjusting for HIV status, SEC, and puberty (as well as after adjusting for sitting height 
percentage and/or leg length). There was no significant difference in age, wealth, or HIV status between 
the sexes for the sample as a whole, although boys were slightly but statistically significantly more 
stunted than girls (unadjusted difference (95%CI) HAZ: -0.2 (-0·4;-0·04)). 
There were no statistically significant differences in spirometry outcomes for those exposed to tobacco 
smoke at home or for those who lived in homes that cooked with biofuel inside (wood/charcoal).  Sex-
stratified analysis of the whole sample found no statistically significant difference in FEV1 or FVC z-
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scores for males exposed and unexposed to household cooking smoke. However, FEV1 was 0.5 (95%CI 
-0·0; 1·0) z-scores lower (p= 0.059) in females exposed to household smoke than in unexposed females 
(borderline statistical significance; adjusted for HIV and SEC). There were no significant differences 
in FVC or FEV1/FVC z-scores.    
Lean mass index (LMI) as calculated from BIA was positively associated with FEV1 and FVC z-scores 
(after adjusting for HIV, SEC, age, sex and puberty: r2 = 0.26, p<0.0001 for FEV1 z-score; and 0.28, 
p<0.0001 for FVC z-score). SAM (i.e. study group) was not included as a potential confounder in this 
section of analysis as it was found to have no significant effect on lung function in this sample.  
Table 2: Results of simple and multivariable linear regression analysis for spirometry outcomes across the 3 
study groups 
Cases 
(n=201) 
Sibling 
(n= 143) 
Community 
(n=121) 
 Mean 
(SD) 
Mean 
(SD) 
Difference Case - Sibling  Mean 
(SD) 
Difference Case - Community 
Unadjusted 
(95% CI) 
Adjusted  
(95% CI) 
Unadjusted  
(95% CI) 
Adjusted  
(95% CI) 
FEV1 z-score -0·47 
(1·1) 
-0·48 
(1·0) 
0·02 
(-0·2, 0·2) 
0·13 
(-0·2,0·4) 
-0·34 
(1·1) 
-0·13 
(-0·4, 0·1) 
-0·02 
(-0·3, 0·2) 
FVC z-score -0·32 
(1·0) 
-0·38 
(1·1) 
0·06 
(-0·2, 0·3) 
0·20 
(-0·0,0·5) 
-0·15 
(1·1) 
-0·17 
(-0·4, 0·1) 
-0·05 
(-0·3, 0·2) 
FEV1:FVC z-
score 
-0·21 
(0·9) 
-0·15 
(0·9) 
-0·06 
(-0·3, 0·1) 
-0·10 
(-0·3,0·1) 
-0·37 
(1·0) 
0·16 
(-0·1, 0·4) 
0·15 
(-0·1, 0·4) 
Adjusted differences include HIV status, SEC, and puberty. When including sitting height % in the model all p-
values remain >0·05 
 
Predictors of lung function in the case group only 
We also explored whether factors which differed between the cases at admission could predict poor 
spirometry outcomes at 7 years post-discharge (Table 3). There was no significant difference in 
spirometry outcomes according to the degree of wasting, degree of stunting, age at admission or 
presence of oedema at time of admission, after adjusting for HIV status, SEC and puberty. Reported 
birth size, (i.e. mother reported her child being “normal or big” versus “small”) also had no association 
with long-term spirometry outcomes in the case group.  
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Table 3: Results of Linear regression analysis comparing effects of potential predictors of poor long-term 
spirometric lung function in SAM survivors (case group only).  
Potential Predictors  Adjusted (95% CI) 
difference  
z-FEV1 
 
Adjusted (95% CI) 
difference z-FVC  
 
Adjusted(95% CI) 
difference z-
FEV1/FVC 
 
Severely stunted at 
admission (HAZ <-3) 
n=92 vs 105 
0.02 (-0.3, 0.3) 0.25 (-0.1, 0.6) -0.17 (-0.5, 0.1)  
Severely underweight at 
admission (WAZ≤-4) 
n=92 vs 106 
-0.07 (-0.4,0.2) 0.20 (-0.1, 0.5) -0.46* (-0.7, -0.2)  
Oedema at admission 
n=164 vs 34 
0.05 (-0.4,0.5) 0.01 (-0.4, 0.4) 0.25 (-0.1, 0.6) 
HIV +ve vs -ve 
n=53 vs 133 
-0.58* (-0.9, -0.3) -0.49* (-0.8, -0.2) -0.23 (-0.5, 0.0) 
Poorest vs Richest SEC 
n=118 vs 76 
-0.27 (-0.06, 0.0) -0.22 (-0.5, 0.1) 0.01 (-0.3, 0.3) 
Males vs Females 
n=108 vs 91 
0.32* (0.0, 0.6) 0.27 (-0.0, 0.6) 0.06 (-0.2, 0.3) 
Low vs Normal birth 
size 
n=18 vs 176 
-0.02 (-0.6, 0.5) -0.04 (-0.6, 0.5) -0.06 (-0.6, 0.4)  
Original admission age 
≤2 yr vs >2yr 
n=106 vs 93 
-0.22 (-0.5, 0.1)  -0.21 (-0.5, 0.1)  -0.02 (-0.3, 0.3)  
* indicates p<0·05. Results are adjusted for HIV status, SEC and puberty. n for all cases with spirometry results 
=201; n presented for each predictor indicates small numbers of missing data for each variable. HAZ= height for 
age z-score; WAZ= weight-for-age z-score; SEC= socioeconomic circumstance. 
 
DISCUSSION 
When comparing the spirometric lung function of Malawian children who had been admitted seven 
years previously with an episode of SAM, against “healthy” sibling and community controls, all 
children (cases and controls) were found to have significant reductions in spirometry compared to 
international reference data. There were however no significant differences in spirometric lung function 
or oxygen saturation during an exercise test between SAM survivors and controls. In the sample as a 
whole, being HIV positive, female, having less lean mass and having a history of TB were associated 
with lower spirometric z-scores. Although household smoke was not associated with lung function in 
the sample as a whole, when stratified by sex we found that females exposed to indoor cooking smoke 
had a lower mean FEV1 z-score than unexposed females.  
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Deficits in spirometric z-scores compared to the international reference seen in all study groups likely 
reflects common environmental factors such as the high background levels of chronic undernutrition 
and general morbidity found throughout childhood in this region. A recent community survey in urban 
Malawian adults found the prevalence of spirometric restriction was 38.6% using NHANES reference 
ranges (derived from a healthy Caucasian population in United Stated) and 9.0% using local reference 
ranges[29]. Spirometric restriction was significantly associated with low BMI, which supports the 
theory that common environmental factors such as chronic undernutrition, combined with high 
population levels of biofuel exposure and HIV, may be sufficient to cause lung restriction, regardless 
of early SAM exposures.  
Besides high levels of chronic undernutrition, it is important to consider the complex interaction of lung 
function, height, sitting height, and leg length, as this could also diminish the effects of SAM in these 
results. As sitting height as a percentage of standing height was on the hypothesised causal pathway 
between SAM and spirometry outcomes, our results were not adjusted for this variable. However, sitting 
height is an important consideration as spirometry z-scores are based on standing height. Although 
SAM survivors had a significantly lower HAZ, they had a similar sitting height compared with controls 
which could have artificially “improved” their lung function z-scores and hence potentially masked the 
long-term effects of SAM. In an attempt to unravel this, regression models including sitting height 
percentage and leg length were run but had virtually no effect on results; p-values remained insignificant 
for all spirometry outcomes.  
Due to this complication, it is important to emphasise that for their standing height, SAM-survivors 
have preserved lung function compared to controls. Despite results from both animal models and some 
human studies in India which suggest that postnatal malnutrition can cause qualitative changes in lung 
function beyond merely an effect on lung size[30-32], emerging evidence suggests that nutritional 
insults in childhood and/or consequential stunting results in smaller lungs which are not necessarily 
associated with restrictive or obstructive defects[33, 34]. This also seems to be true for our stunted 
SAM-survivors, similar to results recently observed in a population of undernourished Indian 
children[33]. Another study hypothesised that although poor linear growth often does not affect lung 
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function, poor weight gain does, possibly due to its negative effect on muscle function[35]. Our finding 
that lean mass was positively associated with FEV1 and FVC z-scores supports this hypothesis that 
weight, particularly muscle mass, may be more important for lung function than linear growth, 
particularly if weight loss has been substantial.  
The finding that lung function in our cohort of SAM survivors appears preserved to the level of control 
children is particularly interesting considering recently published findings that  survivors of SAM have 
multiple adverse long-term outcomes compared with controls, including low weight- and height-for-
age, and weaker hand grip strength[18]. Such observations could be explained at least in part  by  Hales 
& Barker’s thrifty phenotype hypothesis[36, 37] which emphasises that poor growth is often associated 
with selective preservation of vital organs at the expense of other organs and tissues. This may apply to 
SAM survivors in whom limb growth was compromised during or after the episode of SAM, whereas 
sitting height and lung function appear preserved for the majority of survivors. This pattern of shorter 
legs but preserved torso height may allow lung function to be preserved by decreasing the “load” on the 
lungs, whose primary function is to keep the organs and tissues (especially the brain) supplied with 
oxygen (see load/capacity theory for more detail[38]). While the thrifty phenotype hypothesis 
emphasised “brain sparing”[39], the need for preserved lung function in order to support brain energy 
metabolism is a novel concept hypothesised by these results. It is possible that SAM survivors in this 
study have been successfully “thrifty” in leg growth, thereby preserving an important vital organ; the 
lungs.    
Although these results suggest that lung function is unlikely to be a key area for intervention to curb 
post-SAM mortality, they do highlight some potentially “high risk” groups. One particularly susceptible 
population appears to be children with HIV. There is emerging evidence of an increased prevalence of 
chronic lung disease, including both obstructive and restrictive types, in HIV+ve adults[40, 41]. Despite 
85% (62/73) of the HIV+ve children in this cohort reportedly taking antiretroviral therapy, their lung 
function was relatively impaired when compared with HIV-ve children. Very few studies have 
considered the effect of HIV on lung function in children; there is one recent study in India that also 
found significantly lower FEV1 and FVC in children age 5-12 years with vertically transmitted HIV, 
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the majority of whom were taking antiretroviral therapy[42]. Repeat infections, such as TB, combined 
with lower WAZ and lower lean mass could all contribute to the reduced lung function in the HIV+ve 
group.  
Besides HIV, females in this cohort also had significantly lower FEV1 and FVC z-scores compared with 
males. We hypothesised that this could be due to a deviation from the reference values due to delayed 
puberty in Malawian girls, however the sex difference is still seen in young girls (<9 years) so this is 
unlikely to be the explanation. The sex difference could also reflect differences in body composition or 
biofuel smoke exposure. Males in our cohort had significantly more lean mass than girls (based on 
BIA), hence differences in body composition may have contributed to the observed sex differences in 
spirometry. Although we did not find any overall association between spirometry outcomes and living 
with a tobacco smoker or cooking with solid fuel in the home, differential exposure to cooking smoke 
between the sexes could also be a contributory factor, especially since biofuel smoke was associated 
with spirometry outcomes when our data were stratified by sex. However, we would have expected 
pollution exposure to result in an obstructive pattern rather than the restrictive pattern observed. 
Interventions such as low-pollution cook stoves, currently being evaluated in Malawi 
(http://www.capstudy.org/), could have particular benefits for high risk groups. 
Limitations 
Possible sources of bias in this study include survivor bias, selection bias with regard to controls, and 
observer bias. Since 46% of the case group are known to have died since admission, survivor bias could 
have diminished the observed effects of SAM as only the “healthiest” with the fewest long-term impacts 
are likely to have survived. This survivor bias, as well as high rates of HIV and biomass smoke 
exposure, means that results may not be generalisable to all settings.  In addition, the control group are 
not necessarily representative of the Malawian population as a whole as they were recruited in the same 
communities as survivors of SAM. However, based on mean HAZ and WAZ from Malawi’s 2015 
Demographic and Health Survey (DHS), our community controls appear similar to the general 
population (HAZ -1.3 vs -1.5 in DHS; WAZ -1.2 vs -0.8 in DHS)[43].Selection bias could have also 
affected the community control group if those who chose to participate differed systematically from 
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those who declined. This could not be assessed as data were not available on those who declined or 
dropped-out of the study. Lastly, observer bias could have influenced the results as spirometry is an 
effort-dependant test and operators were not blinded to the case/control status of the participants due to 
risk of data entry errors. However, this is in part mitigated by the fact that those conducting quality 
control and selection of final spirometry traces for analysis were blinded.  
Other limitations of this study include the lack of information on some potential confounders, including 
accurate birth weight data. Birth weight is associated with  long-term adverse effects on lung function[2] 
and is also associated with a higher risk of SAM in infancy[44]. However, using the mother’s estimate 
as to whether the child was “small” or “normal” at birth, we found no association with lung function. 
Finally, it is important to note that our results may be affected by the length of follow-up. It could be 
that small inter-group differences are not yet clinically apparent. Evidence of “lung sparing” growth 
could indicate phenotype adaptation, which might not have apparent adverse consequences until much 
later in life[45]. Future follow-up in adulthood could address this.  
 
Conclusion 
Contrary to our initial hypothesis, we found no significant long-term impact of SAM on lung function 
in surviving children. This could be due to ‘thrifty’ or ‘lung-sparing’ growth preserving sitting height 
and lung function at the expense of limb length. HIV, despite treatment, was associated with adverse 
effects on spirometry outcomes, even at these young ages. Females also had significantly poorer lung 
function than males in this cohort: this could reflect differences in body composition or cooking smoke 
exposure. These groups could be considered high-risk populations in intervention packages seeking to 
improve lung function both in survivors of SAM and in the general population  
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